Cargando…
Roxadustat in the treatment of a hemodialysis patient with anti-erythropoietin antibody-mediated pure red cell aplasia
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573001/ https://www.ncbi.nlm.nih.gov/pubmed/34754441 http://dx.doi.org/10.1093/ckj/sfab134 |
| _version_ | 1784595328564985856 |
|---|---|
| author | Xu, Bojun Liu, Suying Li, Yan Zhao, Liangbin Song, Xinyao Chen, Tong |
| author_facet | Xu, Bojun Liu, Suying Li, Yan Zhao, Liangbin Song, Xinyao Chen, Tong |
| author_sort | Xu, Bojun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8573001 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85730012021-11-08 Roxadustat in the treatment of a hemodialysis patient with anti-erythropoietin antibody-mediated pure red cell aplasia Xu, Bojun Liu, Suying Li, Yan Zhao, Liangbin Song, Xinyao Chen, Tong Clin Kidney J Letter to the Editor Oxford University Press 2021-07-10 /pmc/articles/PMC8573001/ /pubmed/34754441 http://dx.doi.org/10.1093/ckj/sfab134 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of ERA-EDTA. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Letter to the Editor Xu, Bojun Liu, Suying Li, Yan Zhao, Liangbin Song, Xinyao Chen, Tong Roxadustat in the treatment of a hemodialysis patient with anti-erythropoietin antibody-mediated pure red cell aplasia |
| title | Roxadustat in the treatment of a hemodialysis patient with anti-erythropoietin antibody-mediated pure red cell aplasia |
| title_full | Roxadustat in the treatment of a hemodialysis patient with anti-erythropoietin antibody-mediated pure red cell aplasia |
| title_fullStr | Roxadustat in the treatment of a hemodialysis patient with anti-erythropoietin antibody-mediated pure red cell aplasia |
| title_full_unstemmed | Roxadustat in the treatment of a hemodialysis patient with anti-erythropoietin antibody-mediated pure red cell aplasia |
| title_short | Roxadustat in the treatment of a hemodialysis patient with anti-erythropoietin antibody-mediated pure red cell aplasia |
| title_sort | roxadustat in the treatment of a hemodialysis patient with anti-erythropoietin antibody-mediated pure red cell aplasia |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573001/ https://www.ncbi.nlm.nih.gov/pubmed/34754441 http://dx.doi.org/10.1093/ckj/sfab134 |
| work_keys_str_mv | AT xubojun roxadustatinthetreatmentofahemodialysispatientwithantierythropoietinantibodymediatedpureredcellaplasia AT liusuying roxadustatinthetreatmentofahemodialysispatientwithantierythropoietinantibodymediatedpureredcellaplasia AT liyan roxadustatinthetreatmentofahemodialysispatientwithantierythropoietinantibodymediatedpureredcellaplasia AT zhaoliangbin roxadustatinthetreatmentofahemodialysispatientwithantierythropoietinantibodymediatedpureredcellaplasia AT songxinyao roxadustatinthetreatmentofahemodialysispatientwithantierythropoietinantibodymediatedpureredcellaplasia AT chentong roxadustatinthetreatmentofahemodialysispatientwithantierythropoietinantibodymediatedpureredcellaplasia |